Cognitive Function Evaluation and Rehabilitation by a Digital Game: MentalPlus®

NCT04637191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 163

Last updated 2024-03-07

No results posted yet for this study

Summary

Cognitive dysfunction is a frequent adverse event in the postoperative period, especially in elderly patients. The tests commonly used for the detection of postoperative cognitive dysfunction (POCD) are time-consuming, which limits routine use. Consequently, there is a limitation to adopting measures to increase preoperative cognitive reserve and rehabilitation of POCD. That situation incentivizes searching for alternative diagnosis methods to overcome that limitation. Digital games have potential neuromodulator effects and have been used as an alternative to psychotherapeutic treatment. However, the tests used to detect postoperative cognitive dysfunction (POCD) are time-consuming, making it difficult to implement routine screening measures. This presents a challenge for increasing preoperative cognitive reserve and rehabilitating POCD. Researchers are exploring alternative diagnostic methods, such as digital games, to address this challenge. Digital games have potential neuromodulator effects and are an alternative to psychotherapeutic treatments and cognitive rehabilitation. This study aims to validate MentalPlus®, a digital game, as a tool for cognitive assessment, POCD evaluation, and POCD rehabilitation-habilitation of mental skills. It is hypothesized that a digital game could replace the usual neuropsychological tests for detecting POCD.

Conditions

  • Neuropsychological Test

Interventions

DEVICE

MentalPlus®

A digital game named MentalPlus will be used to evaluate the possibility of this game becoming a neuropsychological test.

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER
  • Max Planck Institute for Human Development

    collaborator OTHER
  • Karolinska Institutet

    collaborator OTHER
  • The Cleveland Clinic

    collaborator OTHER
  • University of California, Los Angeles

    collaborator OTHER
  • UMC Utrecht

    collaborator OTHER
  • Harvard Medical School (HMS and HSDM)

    collaborator OTHER
  • Keio University

    collaborator OTHER
  • California Institute of Technology

    collaborator OTHER
  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Livia S Valentin, Ph.D · University of Sao Paulo School of Medicine

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-08
Primary Completion
2022-11-29
Completion
2023-11-29

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04637191 on ClinicalTrials.gov